Immunosenescence Clinical Trial Paper Published

An immunosenescence clinical trial using TruActive MPC 85 was published this week in Frontiers in Immunology. Read “Use of UV Treated Milk Powder to Increase Vaccine Efficacy in the Elderly”.

“We are very excited that such an esteemed publication chose to publish our groundbreaking study of immune response improvement from consuming the immune active proteins contained in our TruActive MPC 85 product,” said Bob Comstock, CEO of Tamarack Biotics.  “As you likely know, immune systems weaken as we age, and TruActive strengthens immune response in the elderly.  The scientific evidence leads us to believe TruActive will keep elderly people well.”